Related Experiment Videos
[Retinal findings in thalassemia (author's transl)]
Klinische Monatsblatter Fur Augenheilkunde
|September 1, 1981
Summary
Two patients with retinal abnormalities were identified as heterozygous carriers of beta-thalassemia due to elevated HbA2 levels. A new method reliably diagnoses thalassemia minima by analyzing hematologic changes.
Area of Science:
- Ophthalmology
- Hematology
- Genetics
Context:
- Retinal neovascularizations, bleeding, and pigmented foci can be indicative of underlying hematologic conditions.
- Beta-thalassemia, a genetic blood disorder, can present with subtle or atypical manifestations.
Purpose:
- To investigate the potential link between specific retinal findings and heterozygous beta-thalassemia.
- To present a reliable electrophoretic-spectrophotometric method for diagnosing thalassemia minima.
Summary:
- Two patients presenting with retinal neovascularizations and bleeding were found to have a raised HbA2 fraction.
- This finding suggests they are heterozygous gene carriers of beta-thalassemia.
- An electrophoretic-spectrophotometric method for determining hematologic changes allows for reliable diagnosis of thalassemia minima.
Impact:
- Highlights the importance of considering hematologic disorders in patients with unexplained retinal pathologies.
- Provides a validated diagnostic tool for thalassemia minima, aiding in early identification and management.
- Contributes to understanding the phenotypic variability of beta-thalassemia carriers.